Oncology Impact Fund (Cayman) Management L.P., 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 136,113 shares at $21.78 ($2.9M) on 2021-05-10, disclosed to the SEC on 2021-05-12.
Open-market sale of $2.9M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.78 | 16,722 | $364K | 12.7% |
| 2 | $21.78 | 16,722 | $364K | 12.7% |
| 3 | $22.46 | 411 | $9K | 0.3% |
| 4 | $20.96 | 13,773 | $289K | 10.1% |
| 5 | $20.96 | 13,773 | $289K | 10.1% |
| 6 | $21.51 | 7,672 |
| $165K |
| 5.8% |
| 7 | $21.51 | 7,672 | $165K | 5.8% |
| 8 | $20.53 | 29,684 | $609K | 21.3% |
| 9 | $20.53 | 29,684 | $609K | 21.3% |
| Total | $21.04 avg | 136,113 | $2.9M | 100% |
| Filing → |
| ITOS | SELL | 2021-11-24 | $8.9M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $1.6M | — | Filing → |
| ITOS | SELL | 2021-10-12 | $4.6M | — | Filing → |